Literature DB >> 5351123

[The capillary barrier for dopa in brain and different organs].

J Constantinidis, J C De La Torre, R Tissot, F Geissbuhler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5351123     DOI： 10.1007/bf00407039

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  9 in total

1.  The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.

Authors:  H Altier; M Moldes; J M Monti
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Central decarboxylation and uptake of L-DOPA.

Authors:  N E Andén; J Engel; A Rubenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  [Cholinesterase activity of the rat kidney].

Authors:  G Delbarre; B Delbarre; P Jobard
Journal:  Experientia       Date:  1972-09-15

5.  Effects of L-dopa alone and in combination with dopa decarboxylase inhibitors on the arterial pressure and heart rate of dogs.

Authors:  D H Minsker; A Scriabine; A L Stokes; C A Stone; M L Torchiana
Journal:  Experientia       Date:  1971-05-15

6.  Effect of chronically administered L-dopa on dopa 5HTP decarboxylase and tyrosine and tryptophan hydroxylases in cat brain.

Authors:  A G Roberge; L J Poirier
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

7.  In vivo assessment of decarboxylase inhibition or potentiation: urinary dopamine and L-dopa output after L-dopa administration.

Authors:  R D Johnson; C R Ruthven; B L Goodwin; M Sandler
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

8.  Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Authors:  U K Rinne; E Birket-Smith; E Dupont; E Hansen; M Hyyppä; R Marttila; B Mikkelsen; H Pakkenberg; J Presthus
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849

9.  Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.

Authors:  D H Minsker; A L Stokes
Journal:  Experientia       Date:  1974-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.